AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

Transcription

1 AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

2 AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description A detailed description of the company s operations and business divisions. - Corporate strategy Analyst s summarization of the company s business strategy. - SWOT Analysis A detailed analysis of the company s strengths, weakness, opportunities and threats. - Company history Progression of key events associated with the company. - Major products and services A list of major products, services and brands of the company. - Key competitors A list of key competitors to the company. - Key employees A list of the key executives of the company. - Executive biographies A brief summary of the executives employment history. - Key operational heads A list of personnel heading key departments/functions. - Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history. Highlights AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company that carries out the design, development, production and commercialization of a wide range of primary care and specialty care medicines. The company s product portfolio includes biologics, prescription pharmaceuticals and vaccines. It offers prescription medicines for treating cardiovascular, metabolic, respiratory, cancer, inflammation, autoimmune, infection and neuroscience diseases. AstraZeneca sells its products through wholly-owned local marketing companies as well as through distributors and local representative offices. The company markets its products principally to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in London, the UK. AstraZeneca Plc Key Recent Developments 3

4 Mar 03, 2016: AstraZeneca patient assistance programs provided hundreds of millions of dollars of support in 2015 to help patients afford medicines Feb 16, 2016: Data analysis platform driving preclinical modelling capabilities in AstraZeneca launched to wider pharmaceutical industry Feb 08, 2016: RHINOCORT Allergy Spray Now Available Over the Counter Nationally Feb 04, 2016: Full-Year and Q Results Feb 04, 2016: AstraZeneca Full-Year and Q Results Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company Additional Details Publisher : Global Data Reference : GDPH3904FSA 4

5 Number of Pages : 105 Report Format : PDF Publisher Information : 5

6 Table Of Contents for AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents 2List of Tables 4List of Figures 5Section 1 - About the Company 6AstraZeneca Plc - Key Facts 6AstraZeneca Plc - Key Employees 7AstraZeneca Plc - Key Employee Biographies 9AstraZeneca Plc - Major Products and Services 10AstraZeneca Plc - Pharmaceutical Pipeline Products Data 12AstraZeneca Plc, Pipeline Products by Therapy Area 12AstraZeneca Plc, Pipeline Products by Development Phase 13AstraZeneca Plc - History 25AstraZeneca Plc - Company Statement 48AstraZeneca Plc - Locations And Subsidiaries 51Head Office 51Other Locations & Subsidiaries 51AstraZeneca Plc - Key Manufacturing Facilities 56Joint Venture 56Section 2 Company Analysis 57AstraZeneca Plc - Business Description 57AstraZeneca Plc - Corporate Strategy 59AstraZeneca Plc - SWOT Analysis 60SWOT Analysis - Overview 60AstraZeneca Plc - Strengths 60Strength - Strong Presence in CVMD Market 60Strength - Focused Research and Development Capabilities 60Strength - Leading Position 60AstraZeneca Plc - Weaknesses 62Weakness - Patent Infringements and Other Disputes 62Weakness - Product Discontinuations 62Weakness - Product Safety Concerns 62AstraZeneca Plc - Opportunities 63Opportunity - Product Launches and Approvals 63Opportunity - Product Pipeline 63Opportunity - Orphan Drug Designation 63Opportunity - Business Initiatives 63AstraZeneca Plc - Threats 65Threat - Competitive Pressures from Generic Manufacturers 65Threat - Reliance on Third Parties 65Threat - Loss of Market Exclusivity 65AstraZeneca Plc - Key Competitors 66Section 3 Company Financial Ratios 67Financial Ratios - Capital Market Ratios 67Financial Ratios - Annual Ratios 68Performance Chart 70Financial Performance 70Financial Ratios - Interim Ratios 71Financial Ratios - Ratio Charts 72Section 4 Company s Lifesciences Financial Deals and Alliances 73AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD AstraZeneca Plc, Recent Deals Summary 75Section 5 Company s Recent Developments 76Mar 03, 2016: AstraZeneca patient assistance programs provided hundreds of millions of dollars of support in 2015 to help patients afford medicines 76Feb 16, 2016: Data analysis platform driving preclinical modelling capabilities in AstraZeneca launched to wider pharmaceutical industry 77Feb 08, 2016: RHINOCORT Allergy Spray Now Available Over the Counter Nationally 78Feb 04, 2016: Full-Year and Q Results 79Feb 04, 2016: AstraZeneca Full-Year and Q Results 81Feb 04, 2016: AstraZeneca Announces Full-Year and Q Results 92Dec 16, 2015: AstraZeneca continues strategic investment in China to accelerate delivery of innovative biologics and targeted medicines 97Dec 15, 2015: Controlling the Social Life of Proteins Aims to Transform Drug Discovery 98Dec 14, 2015: AZ Investment Gives Local Economy Early Christmas Present 99Nov 20, 2015: AstraZeneca and Sanofi exchange over 200,000 chemical compounds 100Section 6 Appendix 101Methodology 101Ratio Definitions 101About GlobalData 105Contact Us 105Disclaimer 105 6

7 List Of Tables in AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review List of Tables AstraZeneca Plc, Key Facts 6 AstraZeneca Plc, Key Employees 7 AstraZeneca Plc, Key Employee Biographies 9 AstraZeneca Plc, Major Products and Services 10 AstraZeneca Plc, Number of Pipeline Products by Therapy Area 12 AstraZeneca Plc, Number of Pipeline Products by Development Stage 13 AstraZeneca Plc, Pipeline Products By Therapy Area and Development Phase 14 AstraZeneca Plc, History 25 AstraZeneca Plc, Subsidiaries 51 AstraZeneca Plc, Key Manufacturing Facilities 56 AstraZeneca Plc, Joint Venture 56 AstraZeneca Plc, Key Competitors 66 AstraZeneca Plc, Ratios based on current share price 67 AstraZeneca Plc, Annual Ratios 68 AstraZeneca Plc, Interim Ratios 71 AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD AstraZeneca Plc, Recent Deals Summary 75 Currency Codes 101 Capital Market Ratios 101 Equity Ratios 102 Profitability Ratios 102 Cost Ratios 103 Liquidity Ratios 103 Leverage Ratios 104 Efficiency Ratios 104 7

8 List Of Figures, Charts and Diagrams in AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review List of Figures AstraZeneca Plc, Pipeline Products by Therapy Area 12 AstraZeneca Plc, Pipeline Products by Development Phase 13 AstraZeneca Plc, Performance Chart ( ) 70 AstraZeneca Plc, Ratio Charts 72 AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD

9 How to Buy... AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $125 Single User Price $250 Site License Price $375 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9